Form 4: Guardant Health's Chief Legal Officer Reports Stock Transactions
SEC Form 4 Filing
John G. Saia, Chief Legal Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On June 1, 2024, John G. Saia, the Chief Legal Officer of Guardant Health, Inc., reported transactions involving the company's common stock.
- Saia acquired 263 shares of common stock upon the vesting of restricted stock units (RSUs).
- 94 shares were withheld by the company to cover tax obligations related to the vesting of the RSUs at a price of $27.1 per share.
- Following these transactions, Saia directly owns 25,834 shares of Guardant Health common stock and 1,316 restricted stock units.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders as they relate to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| September 1, 2022 | Initial vesting date for 25% of the restricted stock units. |
| June 1, 2024 | Date of stock acquisition and tax withholding. |
| June 3, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.